Seizures are one of the most common presenting symptoms in the emergency room following COC and METH overdose. Because of increasing trends in the abuse of high quantities of COC and METH, it is important to elucidate the sequelae of toxic-dose consumption of these stimulants. Although the mechanisms of COC- and METH-mediated seizures are poorly defined, previous studies have demonstrated marked differences in the temporal and phenotypic features of seizures induced by COC and METH. More recent findings have demonstrated a differential sensitivity of COC and METH-induced seizure activity to established anti-epileptic drugs. These findings have led to the hypothesis that """"""""the neurochemical and neuroanatomical mechanisms of seizures induced by COC and METH are different."""""""" The overall objective of this proposal is to identify specific differences in the phenotypic and electrographic features of seizures induced by COC and METH. This will be achieved by conducting systematic comparative studies in well-define rat model systems.
In SPECIFIC AIM A we will identify the phenotypic and electrographic features of seizures induced by METH and COC by establishing the dose-dependent proconvulsant characteristics of METH and COC in normal rats. We also propose to assess the ability of COC and METH to modify seizure threshold and determine whether acute and chronic COC and METH exposure facilitates the expression and/or acquisition of limbic kindling.
In SPECIFIC AIM B we will employ pharmacological, anatomical, electrophysiological, and neurochemical approaches to delineate the mechanisms contributing to the proconvulsant properties of COC and METH. Results form studies outlined in SPECIFIC AIM C will determine whether prior METH or COC exposure alters the pro- convulsant properties of the stimulants. We believe these studies will elucidate the neurochemical and neuroanatomical mechanism(s) and consequences of stimulant-induced seizures, leading to the development of more rational and selective therapies to treat the short- and long-term consequences of stimulant-related seizures.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
1P01DA013367-01A1
Application #
6409487
Study Section
Special Emphasis Panel (ZRG1)
Project Start
2001-09-01
Project End
2006-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
German, Christopher L; Gudheti, Manasa V; Fleckenstein, Annette E et al. (2017) Brain Slice Staining and Preparation for Three-Dimensional Super-Resolution Microscopy. Methods Mol Biol 1663:153-162
Baladi, Michelle G; Nielsen, Shannon M; McIntosh, J Michael et al. (2016) Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behav Pharmacol 27:422-30
Fricks-Gleason, Ashley N; German, Christopher L; Hoonakker, Amanda J et al. (2016) An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Synapse 70:139-46
German, Christopher L; Baladi, Michelle G; McFadden, Lisa M et al. (2015) Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev 67:1005-24
Vieira-Brock, Paula L; McFadden, Lisa M; Nielsen, Shannon M et al. (2015) Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. J Pharmacol Exp Ther 355:463-72
Alburges, Mario E; Hoonakker, Amanda J; Cordova, Nathaniel M et al. (2015) Effect of low doses of methamphetamine on rat limbic-related neurotensin systems. Synapse 69:396-404
Vieira-Brock, Paula L; McFadden, Lisa M; Nielsen, Shannon M et al. (2015) Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits. Int J Neuropsychopharmacol 18:
McFadden, Lisa M; Vieira-Brock, Paula L; Hanson, Glen R et al. (2015) Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology 93:146-54
German, Christopher L; Fleckenstein, Annette E; Hanson, Glen R (2014) Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci 97:2-8
Baladi, Michelle G; Nielsen, Shannon M; Umpierre, Anthony et al. (2014) Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats. Behav Pharmacol 25:758-65

Showing the most recent 10 out of 73 publications